Sunday 2 January 2022

Two studies provide good news for the antiviral drug remdesivir.


By BY GINA KOLATA from NYT Science https://ift.tt/31hp5jB
on
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)